Literature DB >> 34505186

Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder.

Majd Al-Soleiti1,2, Kayla Balaj3,4, Robyn P Thom5,6, Christopher J McDougle7,8, Christopher J Keary5,6.   

Abstract

There is increasing interest in investigating cannabis for behavioral symptoms in individuals with autism spectrum disorder (ASD). The potential role of dysregulated cannabinoid signaling contributing to the pathophysiology of ASD is an area of active investigation. Results from retrospective and uncontrolled trials of cannabis in subjects with ASD have been published, reporting both potential benefits and adverse effects. Here, we describe the clinical course of three young adult males with ASD who developed mania or psychosis after the consistent use of cannabidiol and delta-9-tetrahydrocannabinol. Caution should be utilized with cannabis use in individuals with ASD until large-scale, replicated randomized controlled trials demonstrating efficacy, safety and tolerability have been published.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Autism; Autism spectrum disorder; Cannabidiol; Cannabis; Clinical trials; Delta-9-tetrahydrocannabinol

Mesh:

Year:  2021        PMID: 34505186     DOI: 10.1007/s10803-021-05254-8

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  4 in total

1.  Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting.

Authors:  Mary Barna Bridgeman; Daniel T Abazia
Journal:  P T       Date:  2017-03

2.  Ethical Implications for Providers Regarding Cannabis Use in Children With Autism Spectrum Disorders.

Authors:  Susanne W Duvall; Olivia Lindly; Katharine Zuckerman; Michael E Msall; Melissa Weddle
Journal:  Pediatrics       Date:  2019-01-04       Impact factor: 7.124

3.  A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans.

Authors:  Sophie A Millar; Nicole L Stone; Andrew S Yates; Saoirse E O'Sullivan
Journal:  Front Pharmacol       Date:  2018-11-26       Impact factor: 5.810

4.  Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities.

Authors:  Dana Barchel; Orit Stolar; Tal De-Haan; Tomer Ziv-Baran; Naama Saban; Danny Or Fuchs; Gideon Koren; Matitiahu Berkovitch
Journal:  Front Pharmacol       Date:  2019-01-09       Impact factor: 5.810

  4 in total
  2 in total

Review 1.  The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System.

Authors:  Marco Colizzi; Riccardo Bortoletto; Rosalia Costa; Sagnik Bhattacharyya; Matteo Balestrieri
Journal:  Int J Environ Res Public Health       Date:  2022-05-05       Impact factor: 4.614

2.  Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis.

Authors:  Riccardo Bortoletto; Marco Colizzi
Journal:  Healthcare (Basel)       Date:  2022-08-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.